9 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01174 | AP | ACDCRGDCFCGGGGIVRRADRAAVP | Endostatin derived synthetic peptide | Necrosis; Antiangiogenesis | MTT/MTS assay | BAE | Tumor | 50% inhibition at 2.5 µg/ml |
| dbacp01175 | AP | ACDCRGDCFCGGGGIVRRADRAAVP | Endostatin derived synthetic peptide | Necrosis; Antiangiogenesis | MTT/MTS assay | BAE | Tumor | 40% inhibition at 5 µg/ml |
| dbacp01176 | AP | ACDCRGDCFCGGGGIVRRADRAAVP | Endostatin derived synthetic peptide | Necrosis; Antiangiogenesis | MTT/MTS assay | BAE | Tumor | 75% inhibition at 10 µg/ml |
| dbacp01177 | AP(O) | ACDCRGDCFCGGGGIVRRADRAAVP | Endostatin derived synthetic peptide | Necrosis; Antiangiogenesis | MTT/MTS assay | BAE | Tumor | 40% inhibition at 2.5 µg/ml |
| dbacp01178 | AP(O) | ACDCRGDCFCGGGGIVRRADRAAVP | Endostatin derived synthetic peptide | Necrosis; Antiangiogenesis | MTT/MTS assay | BAE | Tumor | 42% inhibition at 5 µg/ml |
| dbacp01179 | AP(O) | ACDCRGDCFCGGGGIVRRADRAAVP | Endostatin derived synthetic peptide | Necrosis; Antiangiogenesis | MTT/MTS assay | BAE | Tumor | 52% inhibition at 10 µg/ml |
| dbacp02914 | ES-2 | IVRRADRAAVP | Endostatin derived synthetic peptide | Necrosis; Anti-angiogenesis | MTT/MTS assay | BAE | Tumor | 60% inhibition at 2.5µg/ml |
| dbacp02915 | ES-2 | IVRRADRAAVP | Endostatin derived synthetic peptide | Necrosis; Anti-angiogenesis | MTT/MTS assay | BAE | Tumor | 60% inhibition at 5µg/ml |
| dbacp02916 | ES-2 | IVRRADRAAVP | Endostatin derived synthetic peptide | Necrosis; Anti-angiogenesis | MTT/MTS assay | BAE | Tumor | 60% inhibition at 10µg/ml |